Japanese pharma firm permits commercialisation of GI drug in India
Japan-based Takeda Pharmaceuticals entered into non-exclusive patent licensing agreements to commercialise Vonoprazan tablets with Sun Pharma and Cipla.
Japan-based Takeda Pharmaceuticals entered into non-exclusive patent licensing agreements to commercialise Vonoprazan tablets with Sun Pharma and Cipla.
Despite slowdown blues, Mitsubishi Electric’s Rajeev Sharma says India is better compared to markets like the U.S. and Europe.